My June purchase I did spread over 2 positions in my portfolio.
I bought 5 shares McDonalds bringing my total number of McDonalds shares to 11. Also I increased my position in AbbVie again. I added 12 shares and now own a total of 35 shares AbbVie. AbbVie is now one of my largest positions in my stock portfolio.
With these 2 purchases I increased my expected yearly dividend income with $66,28
This week I purchased 8 additional shares AbbVie at a price of $95,85. This brings my total position in AbbVie on 23 shares. With this purchase my yearly estimated dividend income increased with $7,96.
AbbVie is down 23% from the high course of $123,21 reached at the end of January. This is mainly due to Abbvie backing away from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer. As I didn’t want to put my full monthly deposit in the speculative purchase of Washington Prime Group, I decided to also buy a few additional shares of AbbVie now the share price is down a bit.
Current yield of AbbVie based on a quarterly dividend of $0,96 is 4,0%.
Today AbbVie announced that the quarterly dividend will be increased from $0,71 to $0,96. This is an increase of 35%.
I have 15 shares AbbVie so this dividend increase results in an estimated yearly dividend increase of $15,00.
The yield on cost after this dividend increase is 5,90%.